Literature DB >> 23568051

Liver toxicity of anabolic androgenic steroid use in an adolescent with nonalcoholic fatty liver disease.

Hannah I Awai1, Elizabeth L Yu, Linda S Ellis, Jeffrey B Schwimmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23568051      PMCID： PMC3772995          DOI： 10.1097/MPG.0b013e3182952e74

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  7 in total

1.  Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats.

Authors:  L D Boada; M Zumbado; S Torres; A López; B N Díaz-Chico; J J Cabrera; O P Luzardo
Journal:  Arch Toxicol       Date:  1999-11       Impact factor: 5.153

Review 2.  Abuse of supraphysiologic doses of anabolic steroids.

Authors:  Ryan C W Hall; Richard C W Hall
Journal:  South Med J       Date:  2005-05       Impact factor: 0.954

Review 3.  Fatty liver and ischemia/reperfusion: are there drugs able to mitigate injury?

Authors:  Ana T Varela; Anabela P Rolo; Carlos M Palmeira
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Muscle-enhancing behaviors among adolescent girls and boys.

Authors:  Marla E Eisenberg; Melanie Wall; Dianne Neumark-Sztainer
Journal:  Pediatrics       Date:  2012-11-19       Impact factor: 7.124

Review 5.  Current concepts in anabolic-androgenic steroids.

Authors:  Nick A Evans
Journal:  Am J Sports Med       Date:  2004-03       Impact factor: 6.202

6.  Androgenic/Anabolic steroid-induced toxic hepatitis.

Authors:  Davor Stimac; Sandra Milić; Renata Dobrila Dintinjana; Drazen Kovac; Smiljana Ristić
Journal:  J Clin Gastroenterol       Date:  2002-10       Impact factor: 3.062

7.  Anabolic-androgenic steroids and liver injury.

Authors:  Magdalena Sánchez-Osorio; Andrés Duarte-Rojo; Braulio Martínez-Benítez; Aldo Torre; Misael Uribe
Journal:  Liver Int       Date:  2007-09-26       Impact factor: 5.828
  7 in total
  4 in total

Review 1.  New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants.

Authors:  Mauro Cataldi; Vincenzo Citro; Chiara Resnati; Federica Manco; Giovanni Tarantino
Journal:  Adv Ther       Date:  2021-03-24       Impact factor: 3.845

Review 2.  Anabolic-androgenic steroids and cardiovascular risk.

Authors:  Jian-Di Liu; Yan-Qing Wu
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

Review 3.  Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.

Authors:  Xuelin Zhang; Yang Wang; Pingsheng Liu
Journal:  Protein Cell       Date:  2016-10-18       Impact factor: 14.870

Review 4.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.